Organization · Venture Studio
SmartHealth Catalyzer, Inc.
SmartHealth Catalyzer, Inc. is a biomedical venture studio based in the Midwest, focused on building startups around innovations in therapeutics, diagnostics, and medical devices from local universities and research hospitals.
Overview
What SmartHealth Catalyzer, Inc. does
What SmartHealth Catalyzer, Inc. is
SmartHealth Catalyzer, Inc. is a biomedical venture studio based in the Midwest, focused on building startups around innovations in therapeutics, diagnostics, and medical devices from local universities and research hospitals.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2026
- Structured capabilities
- Funder · Program host
- Last reviewed
- May 3, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find SmartHealth Catalyzer, Inc. elsewhere
Open the official website or a supported primary organization account.
Capability profile
SmartHealth Catalyzer, Inc. as a funder
Investment thesis
SmartHealth Catalyzer focuses on biomedical research with startup potential at Midwest universities and research hospitals, emphasizing the need for an experienced operating layer to transition innovations into commercial ventures.
Focus narrative
SmartHealth Catalyzer invests in life science innovations, specifically targeting therapeutics, diagnostics, and medical devices. The organization collaborates with universities and research hospitals to accelerate the commercialization of groundbreaking biomedical innovations. Their support includes licensing, intellectual property protection, technology transfer, corporate creation, and operational strategy for early-stage life science companies.
Value beyond capital
SmartHealth Catalyzer adds value by providing comprehensive support in areas such as intellectual property protection, technology transfer, corporate creation, and operational strategy. They help startups navigate the complexities of commercialization, investor readiness, and market presence, ensuring that biomedical innovations reach their full potential.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Saros Therapeutics: Develops novel medicines targeting cancer using the STING pathway with lipid nanoparticle technology. 32 Biosciences: Focuses on gastrointestinal diseases, aiming to restore and protect the GI mucosal-immune system with a proprietary discovery platform. bionode: Works on a smartlens system to reduce intraocular pressure in glaucoma patients, demonstrating significant clinical trial success. Cadenza Bio: Developing orally available small molecule drugs for remyelination and inflammation in Multiple Sclerosis patients. Delphian Therapeutics: A clinical-stage company focused on endocannabinoid system modulation to treat pain and neurological disorders, with NIH funding. Atzeyo: Created a diagnostic platform for oncologists that combines the speed of point-of-care testing with the accuracy of core lab instruments.
Capability profile
SmartHealth Catalyzer, Inc. as a program host
Program thesis
SmartHealth Catalyzer focuses on building biomedical startups around innovations from Midwest universities and research hospitals, aiming to commercialize therapeutics, diagnostics, and medical devices.
Focus narrative
SmartHealth Catalyzer invests in life science innovations, specifically targeting therapeutics, diagnostics, and medical devices. The organization collaborates with universities and research hospitals to address significant health challenges, providing support in areas such as intellectual property protection, technology transfer, corporate creation, and operational strategy for early-stage life science companies.
Value and support
SmartHealth Catalyzer offers mentorship, operational support, and strategic guidance to biomedical startups, helping them navigate the commercialization process from research to market.
Additional public guidance
Q: What is SmartHealth Catalyzer? A: A biomedical venture studio focused on building startups from university innovations. Q: What sectors do you focus on? A: We focus on therapeutics, diagnostics, and medical devices.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- North AmericaUnited States
Alumni and track record
Alumni context
Notable alumni include Saros Therapeutics, which develops novel cancer medicines; 32 Biosciences, focusing on gastrointestinal diseases; and bionode, which has created a smartlens system for glaucoma patients.
Common questions
What to know about SmartHealth Catalyzer, Inc.
Upseed classifies SmartHealth Catalyzer, Inc. under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.